13F
中

KYTX KYVERNA THERAPEUTICS INC

2026Q1 · CUSIP 501976104 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
109
Δ holders QoQ
+9
Breadth percentile
Top 31%
Whale holders
55
Δ whales
+3
Inst. holding value
$300M
New positions
26
Closed positions
17
Price momentum (1Q)
+12.5%
Put / Call
1/4

Breadth history (34 quarters)

2024Q2: Δ-1 · h=89 2024Q3: Δ+5 · h=94 2024Q4: Δ-5 · h=89 2025Q1: Δ-2 · h=87 2025Q2: Δ-7 · h=80 2025Q3: Δ-4 · h=76 2025Q4: Δ+24 · h=100 2026Q1: Δ+9 · h=109 2024Q2: holders=89 2024Q3: holders=94 2024Q4: holders=89 2025Q1: holders=87 2025Q2: holders=80 2025Q3: holders=76 2025Q4: holders=100 2026Q1: holders=109 -24 -12 +0 +12 +24 6892115 24Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
1
QoQ: -2
Call holders
4
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-3.27
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2024-06-30: EPS -0.67 2024-09-30: EPS -0.80 2024-12-31: EPS -0.74 2025-03-31: EPS -1.03 2025-06-30: EPS -0.97 2025-09-30: EPS -0.85 2025-12-31: EPS -0.79 2026-03-31: EPS -0.66 -1.13 -0.57 0.00 2023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)